Clients receiving targeted therapy to treat cancer need to avoid which food?

A. “I will not need to know how to check my body temperature.”:

This statement is incorrect. Monitoring body temperature is important for patients receiving chemotherapy because a compromised immune system increases the risk of infection. Fever can be an early sign of infection, and patients are often instructed to monitor their temperature regularly.

B. “Chemotherapy is excreted in my bodily fluids.”:

This statement is correct. Chemotherapy drugs can be excreted in various bodily fluids, such as urine, sweat, and saliva. Patients are advised to take precautions to avoid exposing others to these bodily fluids during and shortly after chemotherapy.

C. “My spouse will wear gloves when emptying my urinal.”:

This statement is correct. To reduce the risk of exposure to chemotherapy drugs in urine, it is advisable for caregivers, such as spouses, to wear gloves when handling bodily fluids.

D. “The chemotherapy will remain in my body for 2-3 days.”:

This statement is correct. The duration during which chemotherapy remains in the body can vary depending on the specific drugs administered. Patients are typically provided with guidelines on how long they need to take precautions to minimize exposure to others.

A. Epinephrine

Epinephrine is a bronchodilator that can be used in emergencies to treat acute bronchospasm. It works by relaxing the smooth muscles in the airways and can be administered via inhalation or injection. However, it is not typically the first-line treatment for COPD, and other bronchodilators are often preferred.

B. Montelukast (Singulair)

Montelukast is a leukotriene receptor antagonist that is used for the long-term control and prevention of symptoms in conditions like asthma, but it is not typically used for acute bronchospasm. It is more commonly used for maintenance therapy to prevent exacerbations.

C. Theophylline

Theophylline is a bronchodilator that can be used to treat acute bronchospasm in COPD. However, it is not commonly used as a first-line treatment due to its narrow therapeutic range and potential for side effects. It may be considered in certain cases when other bronchodilators are not well-tolerated or effective.

D. Tiotropium Bromide (Spiriva)

Tiotropium bromide is a long-acting antimuscarinic bronchodilator used for the long-term maintenance treatment of COPD. It is not typically prescribed for the treatment of acute bronchospasm but rather for the prevention of symptoms over the long term.